SPPH OTC
Spencer Pharmaceutical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$4M
+911.0% ▲
Total Liabilities
$380K
-54.8% ▼
Shareholders Equity
$4M
+1018.4% ▲
Cash & Investments
$21K
-93.1% ▼
Total Debt
$154K
+0.0% ▲
Net Debt
$133K
+143.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2001 | FY2002 | FY2003 |
|---|---|---|---|
| — Assets — | |||
| Cash | $1M | $304K | $21K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $1M | $304K | $21K |
| Net Receivables | $436K | $300 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $278K |
| Total Current Assets | $2M | $374K | $299K |
| Property, Plant & Equip. | $32K | $38K | $0 |
| Goodwill & Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $8K | $8K | $4M |
| Total Non-Current Assets | $40K | $46K | $4M |
| Total Assets | $2M | $419K | $4M |
| — Liabilities — | |||
| Accounts Payable | $354K | $819K | $225K |
| Short-Term Debt | $0 | $0 | $154K |
| Deferred Revenue | $360K | $0 | $0 |
| Other Current Liabilities | $40K | $0 | $0 |
| Total Current Liabilities | $780K | $839K | $380K |
| Long-Term Debt | $0 | $0 | $0 |
| Other Non-Current Liab. | $900K | $0 | $0 |
| Total Non-Current Liabilities | $900K | $0 | $0 |
| Total Liabilities | $2M | $839K | $380K |
| — Equity — | |||
| Common Stock | $2K | $2K | $4M |
| Retained Earnings | -$2M | -$4M | -$5M |
| Accumulated OCI | -$369K | $0 | $288K |
| Total Stockholders Equity | $281K | -$420K | $4M |
| Total Liabilities & Equity | $2M | $419K | $4M |
| — Key Metrics — | |||
| Total Debt | $0 | $0 | $154K |
| Net Debt | -$1M | -$304K | $133K |
| Total Investments | $0 | $0 | $0 |